Skip to main content
Equibles
UTI logo

UTI · Universal Technical Institute Inc

Track UTI — free

Use UTI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research UTI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$21.47 +0.65 (+3.12%) At close · Sep 18
S&P 600 member Russell 2000 member Rebalance outlook locked
Market Cap
$1.13B
Shares
55.10M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$21.47 Open$20.89 Day$20.50–21.70 52W close$20.31–51.20 Avg vol 30d1.8M Short int5.5M · 10.0% float · 3.0d Short vol50% Last earningsAug 5, 2026 DataJan 2020–Sep 2026 Filing10-Q · Aug 6

Up next

Next earnings call
Nov 4, 2026 Est · unconfirmed · in 6 wks
Latest filing: 10-Q
filed Aug 6, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
$883.60M
Trailing 12 months
Net income (TTM)
$34.30M
Trailing 12 months
Revenue growth YoY
+7.2%
Year over year
Operating margin
5.0%
Trailing 12 months
P / E (TTM)
35.2
Trailing earnings · reciprocal yield 2.8%
FCF yield
-2.0%
TTM · current market cap
Return on invested capital
10.0%
Trailing 12 months
Net cash
$10.09M
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+0.5%
Year over year · more shares
Price change (1Y)
-24.9%
Trailing year
Short interest
10.0%
Latest settlement · 3.0 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Sell
SellHoldBuy
Technical Sell Momentum Very Weak Sentiment Neutral Fundamentals Excellent Quant / Vol Very High
Market backdrop VIX 14.8 · calm Equity put/call 0.58
Technical
price trend
Sell
50 / 200-day cross No cross
Price vs 200-day avg −35%
below
Price vs 50-day avg −28%
below
RSI (14) 36
neutral
MACD trend Positive
52-week position 4%
near low
Volume (OBV) Confirms
volume backs price
Momentum
relative strength
Very Weak
1-month return −6%
trailing
6-month return −42%
trailing
YTD return −18%
this year
Relative strength −62%
vs S&P · 6-mo
Sentiment
smart money
Neutral
Trend (MA cross) No cross
50d $30 › 200d $33 — 200d above 50d
Institutional flow Accumulating
+7% holders QoQ · +53 funds added
Insider flow Distributing
Net -$3.8M over 90 days · 67% sells
Short interest Rising
9.96% of float · ▲ +8.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
268 holders — near 3-yr high, broad support
Squeeze score 51
elevated · 0–100
Fundamentals
Excellent
Revenue growth +14%
Y/Y
EPS growth +51%
Y/Y
Free cash flow $55.4M
Valuation P/E 33.6
rich
Buyback $35.0M
authorized
Balance sheet $40.3M
net cash
Quant / Vol
risk profile
Very High
Volatility 68%
annualized · 1-yr
Max drawdown −60%
past year
ATR 6.7%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Guidance & track record

Beat or met 3 of last 4
Latest guidance · from the Earnings Call filed Aug 5, 2026
fiscal 2026
Consolidated revenue Initiated $893M – $900M
prior FY $835.62M midpoint +7.3% Y/Y
Net income Initiated $32M – $36M
Diluted earnings per share Initiated $0.57 – $0.64
prior FY $1.13 midpoint −46.5% Y/Y
Reported adjusted EBITDA Initiated $100M – $103M
Baseline adjusted EBITDA Initiated at least $135M
Capital expenditures Initiated $110M
2029
Revenue at least $1.2B
prior FY $835.62M midpoint +43.6% Y/Y
Adjusted EBITDA up to $220M
Prior guidance period ended · from the 8-K filed May 8, 2024
Diluted EPS · FY 2024 $0.68 – $0.73
Adjusted EBITDA margin · fiscal year 2025 15%
Revenue · fiscal 2024 $720M – $730M
Net Income · fiscal 2024 $37M – $41M
Adjusted EBITDA · fiscal 2024 $102M – $104M
Guided vs delivered · last 4 settled
Diluted EPS FY 2024
guided $0.68 – $0.73
$0.75 Beat +6.4%
Revenue fiscal 2024
guided $720M – $730M
$732.69M Beat +1.1%
Revenue fiscal year 2022
guided $405M – $420M
$418.77M In line
Total revenue full year
guided $338M – $345M
$300.76M Miss −11.9%

Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

Technicals

trend & momentum for long-term holders Sell
3 · 3 · 1
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−35% Bearish
Price vs 50-day avg
−28% Bearish
RSI (14)
36 Neutral
MACD trend
Positive Bullish
52-week position
4% Bearish
Volume (OBV)
Confirms Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross) No cross
50d $30 › 200d $33 — 200d above 50d
Institutional flow Accumulating
+7% holders QoQ · +53 funds added
Insider flow Distributing
Net -$3.8M over 90 days · 67% sells
Short interest Rising
9.96% of float · ▲ +8.3% MoM · 3.0 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr high
268 holders — near 3-yr high, broad support
Price context
position in its 52-week range
Range low $20 Now $21 · 4% Range high $51
vs 200-day avg -35% vs 50-day avg -28%

Illustrative technical + ownership context — a signal mix, not investment advice.

Key metrics

Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.

Versus peers

Education & Training Services — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
UTI
Universal Technical Institute Inc
this stock
$1.13B -17.8% +14.0% 33.6 10.0%
EDU
New Oriental Education & Technology Group Inc.
 $9.26B +1.1% +13.6% — 2.0%
TAL
TAL Education Group
 $6.55B +8.2% +33.7% — 3.9%
LAUR
Laureate Education, Inc.
 $4.98B +7.3% +19.5% 16.4 2.6%
CVSA
Covista Inc.
 $4.33B +22.5% +9.3% 18.1 5.2%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
268
% held
114.2%
Net QoQ
+5.5M sh
Top holder
BlackRock, Inc.
Held Float
View
Held by Funds
Fund positions
287
View
Short & Settlement
Short Interest Rising
Shares short
5.5M
Days to cover
3.0d
Change
+422.1K sh
View
Short Volume
Short vol %
50%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
20
Value
$501
As of
Aug 19, 2026
View
Off-Exchange
Off-exchange %
43.2%
Week of
Aug 10, 2026
Off-exch Lit
View
Smart Money
Insider Trades Net selling
Net (90d)
-$3.8M
Buyers / Sellers
1 / 2
Buyers Sellers
View
Financials
Financials
Revenue (FY)
$835.6M
Net income (FY)
$63.0M
EPS diluted
$1.13
View
Buybacks
Authorized
$35.0M
View
Filings
SEC Filings
Latest
8-K
Filed
Aug 18, 2026
This year
10
View
Proposed Sales
Value
$3.9M
Shares
94.5K
Filed
Jun 29, 2026
View
Earnings & Events
Earnings Calls Upcoming
Next call
Sep 22, 2026
Last call
Aug 5, 2026
View
Investor Relations
Upcoming events
1
View

Performance

5D 20D 120D MTD YTD
UTI +5.7% -6.3% -42.3% +1.6% -17.8%
SPY -0.3% -0.1% +20.1% -0.7% +11.7%
vs SPY +6.1% -6.2% -62.4% +2.3% -29.5%

Capital returns

Buyback program · as of Jun 30, 2025
Authorized
$35.00M
Spent (derived)
—
Remaining
—

Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

Key facts CIK 1261654 CUSIP 913915104 13F (30d) 8 filings 8 filers Visit website Investor relations